KULR Technology extends ATM offering pause through September 2026.
The company announced the extension of its ATM equity offering pause through September 2026 to shield shareholders from dilution. Instead of issuing new equity, KULR plans to sell …
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
The company announced the extension of its ATM equity offering pause through September 2026 to shield shareholders from dilution. Instead of issuing new equity, KULR plans to sell …
HA Sustainable Infrastructure Capital filed an indenture to issue 5.950% Green Senior Unsecured Notes due 2033. The document confirms the company's plans for a debt offering to rai…
Summit Group CPAs, P.C. confirmed agreement with statements in the company's recent filing. This routine submission establishes compliance with executive compensation reporting sta…
Hyperscale Data filed an 8-K with an investor presentation outlining future plans for AI and robotics campuses in Michigan and Montana. The announcement of new development sites su…
AES stockholders approved the $15.00 per share acquisition by a consortium led by Global Infrastructure Partners. The overwhelming vote supports the expected closing of the deal in…
Veea Inc.'s board approved the issuance of 42,000 shares of Series A-1 Convertible Preferred Stock. The authorization establishes an additional tool for potential capital raising o…
Context Therapeutics amended its charter to authorize 310 million shares. The increase supports potential future financing needs.
Vaxart received additional BARDA funding to advance COVID-19 vaccine data analysis. The release allows the company to report 12-month trial data.
BriaPro Therapeutics Corp. filed unaudited interim financial statements for the period ended April 30, 2026, showing a substantial increase in total assets. The filing highlights a…
SuRo Capital Corp. filed an amendment to change its corporate name to Neostellar Capital Corp. in preparation for a July 1, 2026 effective date. This restructuring will occur witho…
Aligos Therapeutics amended its 2020 Employee Stock Purchase Plan to increase the maximum share issuance to 694,714 shares. This action requires stockholder approval and is intende…
SCYNEXIS amends its certificate of incorporation to authorize 65 million shares. The approval, received in June 2026, establishes the corporate equity capacity for potential future…
Worthington Enterprises awarded performance shares linked to Adjusted EBITDA and Return on Assets. The payout depends on achieving specific financial milestones between 2027 and 20…
Realloys Inc. announced the closing of a $100 million private placement of common stock. Proceeds will be used for working capital and general corporate purposes.
Ernst & Young authorized the use of their audit report within Stryker's current filing to support the financial statements section. This procedural move facilitates the incorporati…
ZRCN Inc. filed a Form 8-K referencing Exhibit 3.1, though the actual filing content was not provided. The market impact is currently neutral pending full review.
The company submitted a regulatory update, typically containing material information such as financial results or operational updates.
Institutional holdings report (13F-HR) filed by First Nebraska Trust Co.
Fidelity Private Credit Fund reported a 10.12% total return since inception and a 9.21% annualized distribution rate for the period ending May 31, 2026. The fund maintains high flo…
The FDA issued a proposed rule to identify illegal foreign tobacco products and protect public health by targeting youth-appealing e-cigarettes.